CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
When asked about CVS Health Corporation (NYSE:CVS) on CNBC's "Mad Money Lightning Round," Jim Cramer said, "I think there's real value here."
當被問及CVS Health Corporation (紐交所:CVS) 在CNBC的"瘋狂金錢閃電輪"節目上,吉姆·克雷默表示:"我認爲這裏有真正的價值。"
On Oct. 10, Barclays analyst Andrew Mok upgraded CVS Health from Equal-Weight to Overweight and raised the price target from $63 to $82.
10月10日,巴克萊銀行分析師安德魯·莫克將CVS Health的評級從Equal-Weight升級爲Overweight,並將價格目標從63美元提高至82美元。
Cramer also recommends buying Micron Technology, Inc. (NASDAQ:MU), saying it had an "amazing" quarter.
克雷默還建議購買美光科技公司 (納斯達克:MU),稱其季度"驚人"。
On Oct. 8, Keybanc analyst John Vinh maintained Micron Technology with an Overweight and lowered the price target from $145 to $135.
10月8日,凱班克分析師約翰·文將美光科技維持爲Overweight,並將價格目標從145美元下調至135美元。
Although Cramer believes Old Dominion Freight Line (NASDAQ:ODFL) will have a good year, but he prefers the stock of Union Pacific (NYSE:UNP).
儘管克雷默認爲Old Dominion Freight Line (納斯達克:ODFL) 將度過一個好年,但他更偏愛聯合太平洋 (紐交所:UNP) 的股票。
On Oct. 9, Citigroup analyst Ariel Rosa initiated coverage on Old Dominion Freight Line with a Neutral rating and announced a price target of $206.
10月9日,花旗集團分析師艾瑞爾·羅莎對Old Dominion Freight Line發起覆蓋,評級爲中立,並宣佈了206美元的價格目標。
The "Mad Money" host recommended not touching American Tower (NYSE:AMT).
《瘋狂金錢》主持人建議不要觸及美國塔架 (紐交所:AMT)。
On Oct. 10, Barclays analyst Tim Long maintained American Tower with an Overweight and raised the price target from $223 to $255.
10月10日,巴克萊銀行分析師蒂姆·朗將美國塔架維持爲Overweight,並將價格目標從223美元上調至255美元。
Cramer said Howmet Aerospace Inc. (NYSE:HWM) is going higher, adding that it is one of the greatest stocks of his time.
克雷默表示howmet aerospace股票(紐交所:HWM)將繼續上漲,並補充說這是他所見過的最好的股票之一。
Howmet Aerospace will announce its third quarter 2024 financial results on Wednesday, Nov. 6.
howmet aerospace將於2024年第三季度業績發佈日週三,11月6日公佈其財務業績。
ADMA Biologics (NASDAQ:ADMA) is a "very speculative" stock, Cramer said.
adma biologics(納斯達克:ADMA)是一隻「很有投機性」的股票,克雷默表示。
On Sept. 20, Cantor Fitzgerald analyst Kristen Kluska reiterated ADMA Biologics with an Overweight and maintained a $20 price target.
9月20日,康泰鉑菲特分析師克里斯汀·克盧斯卡(Kristen Kluska)重申對adma biologics的超配評級,並維持20美元的目標價。
Cramer recommended buying Modine Manufacturing (NYSE:MOD). "It's just one of these great metal-bending companies," he added.
克雷默建議買入摩丁製造(紐交所:MOD)。他補充說:「這只是這些優秀金屬彎曲公司中的一家。」
On Sept. 24, DA Davidson analyst Matt Summerville maintained Modine Manufacturing with a Buy and raised the price target from $140 to $155.
9月24日,DA Davidson分析師馬特·薩默維爾(Matt Summerville)維持摩丁製造的買入評級,並將目標價從140美元上調至155美元。
Robinhood (NASDAQ:HOOD) is a buy, Cramer said.
羅賓漢(納斯達克:HOOD)是一個買入的選擇,克雷默表示。
On Oct. 8, Piper Sandler analyst Patrick Moley maintained Robinhood with an Overweight and maintained a $27 price target.
10月8日,派傑投資分析師帕特里克·莫利(Patrick Moley)維持羅賓漢的超配評級,並維持27美元的目標價。
Price Action:
價格行動:
- Old Dominion shares gained 0.1% to settle at $194.59 on Thursday.
- Micron shares gained 3.9% to close at $105.69.
- American Tower shares fell 1.3% to close at $217.90 on Thursday.
- Howmet Aerospace shares fell 1.5% to close at $102.10 during the session.
- Modine Manufacturing shares fell 2.3% to settle at $130.95 on Thursday.
- ADMA Biologics shares fell 16.3% to settle at $17.01.
- Robinhood shares fell 0.6% to close at $25.50 on Thursday.
- CVS shares gained 1.3% to close at $66.85 on Thursday.
- Old Dominion股票漲了0.1%,週四收於194.59美元。
- 美光科技股票上漲了3.9%,收於105.69美元。
- 美國塔架股票下跌了1.3%,週四收於217.90美元。
- howmet aerospace股票下跌了1.5%,本次交易收盤價爲102.10美元。
- 摩丁製造股票下跌了2.3%,週四收於130.95美元。
- adma biologics股票下跌了16.3%,週四收於17.01美元。
- 羅賓漢股票下跌了0.6%,週四收於25.50美元。
- 西維斯健康股票週四收盤漲1.3%,收於66.85美元。
- Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
- 兩隻醫療保健股票,正在在投資組合中引發重要變化
Image: Shutterstock
圖片:shutterstock
譯文內容由第三人軟體翻譯。